Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (641-650 of 829) with videos related to

Pageof 83
Sort By:
Cancer|November 25, 2010
Sunitinib rechallenge in metastatic renal cell carcinoma patientsIvan N Zama, Thomas E Hutson, Paul Elson, et al.
Blood|February 22, 2007
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphomaYoun H Kim, Madeleine Duvic, Erik Obitz, et al.
Journal of Hepatology|March 5, 2017
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysisGonzalo Sapisochin, Aisling Barry, Mark Doherty, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Clinical Epigenetics|October 3, 2020
TWIST1 DNA methylation is a cell marker of airway and parenchymal lung fibroblasts that are differentially methylated in asthmaRachel L Clifford, Chen Xi Yang, Nick Fishbane, et al.
Nature Nanotechnology|June 26, 2023
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Mohamad-Gabriel Alameh, Kamila Butowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomasM S Kaminski, A D Zelenetz, O W Press, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaAlexis Bujold, Christine A Massey, John J Kim, et al.
Epidemiology and Infection|April 26, 2014
Community-associated methicillin-resistant Staphylococcus aureus transmission in households of infected cases: a pooled analysis of primary data from three studies across international settingsJ Knox, M Van Rijen, A-C Uhlemann, et al.
Pageof 83

Showing results (641-650 of 829) with videos related to

Sort By:
Pageof 83
Cancer|November 25, 2010
Sunitinib rechallenge in metastatic renal cell carcinoma patientsIvan N Zama, Thomas E Hutson, Paul Elson, et al.
Blood|February 22, 2007
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphomaYoun H Kim, Madeleine Duvic, Erik Obitz, et al.
Journal of Hepatology|March 5, 2017
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysisGonzalo Sapisochin, Aisling Barry, Mark Doherty, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Clinical Epigenetics|October 3, 2020
TWIST1 DNA methylation is a cell marker of airway and parenchymal lung fibroblasts that are differentially methylated in asthmaRachel L Clifford, Chen Xi Yang, Nick Fishbane, et al.
Nature Nanotechnology|June 26, 2023
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Mohamad-Gabriel Alameh, Kamila Butowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomasM S Kaminski, A D Zelenetz, O W Press, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaAlexis Bujold, Christine A Massey, John J Kim, et al.
Epidemiology and Infection|April 26, 2014
Community-associated methicillin-resistant Staphylococcus aureus transmission in households of infected cases: a pooled analysis of primary data from three studies across international settingsJ Knox, M Van Rijen, A-C Uhlemann, et al.
Pageof 83